We have previously identified a novel 130 kDa protein (p130) which binds Ins(1,4,5)P $ and shares 38 % sequence identity with phospholipase C-δ " [Kanematsu, Misumi, Watanabe, Ozaki, Koga, Iwanaga, Ikehara and Hirata (1996) Biochem. J. 313, 319-325]. We have now transfected COS-1 cells with genes encoding the entire length of the molecule or one of several truncated mutants, in order to locate the region for binding of Ins(1,4,5)P $ . Deletion of N-terminal residues 116-232, the region which corresponds to the pleckstrin homology (PH) domain of the molecule, completely abolished binding activity. This result was confirmed when the PH domain itself (residues 95-232), isolated from a bacterial expression system, was found to bind [$H]Ins(1,4,5)P $ . We also found that Ins(1,4,5,6)P % was as efficacious as Ins(1,4,5)P
INTRODUCTION
It is now well recognized that many of the proteins that participate in cell signalling contain modular domains that help to regulate interactions between components of signal transduction cascades. One such module is the pleckstrin homology (PH) domain, a region of approximately 120 amino acids that can form an electrostatically polarized tertiary structure [1, 2] . Some PH domains have been shown to bind to PtdIns(4,5)P # and\or Ins(1,4,5)P $ [3] [4] [5] [6] , which themselves are well known to separately participate in intracellular signalling pathways [7, 8] . Therefore current efforts to determine the significance of the ligand binding characteristics of PH domains lie at the heart of the search for their overall physiological significance.
Among the growing number of recognized PH domains, that which is present in phospholipase C-δ " (PLC-δ " ) is so far unique in the detail with which its ligand specificity and functional significance have been analysed. This particular PH domain binds Ins (1, 4, 5) P $ with about 10-fold greater affinity than PtdIns(4,5)P # [5] . A consequence of PLC-δ " binding to Ins (1, 4, 5) P $ is the inhibition of the enzyme's lipid-hydrolysing activity [9, 10] , so it is possible that competition between these that these two polyphosphates bind to p130 with similar affinity. This conclusion was confirmed by direct binding studies using [$H]Ins(1,4,5,6)P % with high specific radioactivity which we prepared ourselves. Binding specificity was also examined with a variety of inositol phosphate derivatives. As is the case with other PH domains characterized to date, we found that the 4,5-icinal phosphate pair was an essential determinant of ligand specificity. However, the PH domain of p130 exhibited some novel features. For example, the 3-and\or 6-phosphates could also contribute to overall binding ; this contrasts with some other PH domains where these phosphate groups decrease ligand affinity by imposing a steric constraint. Secondly, a free monoester 1-phosphate substantially increased binding affinity, which is a situation so far unique to the PH domain of p130.
two ligands in i o may contribute to the overall regulation of PLC-δ " activity. However, it has been pointed out (e.g. [6] ) that the information obtained from PLC-δ " is likely not to be generally applicable ; despite the tertiary structure of PH domains being well conserved between individual proteins, there is nevertheless considerable variation in their primary amino acid sequences. This undoubtedly contributes to the variation that has been observed in the relative ligand affinities of PH domains, and an accompanying diversity in the functional significance of this module is therefore anticipated. For example, the PH domain of pleckstrin has a somewhat specific affinity for PtdIns(4,5)P # , and the soluble Ins(1,4,5)P $ head-group is only an effective competitor when it is present in large excess [3, 5] . In the case of the PH domain of spectrin, the affinities for both PtdIns(4,5)P # and Ins(1,4,5)P $ are sufficiently weak (K d 40 µM) that only the binding of the lipid is likely to be physiologically relevant [4] . Moreover, it appears that the PH domain of human dynamin does not bind either PtdIns(4,5)P # or Ins(1,4,5)P $ [5, 11] . There is clearly a need to examine other PH domains before we can develop any general rules concerning the relationship between primary sequence, tertiary structure and ligand binding proper-ties. To achieve this aim, we have examined whether a recently cloned Ins(1,4,5)P $ binding protein of 130 kDa (p130) [12] might be a useful tool because of its candidate PH domain. This protein shares 38 % sequence identity with PLC-δ " (in regions corresponding to the so-called X-and Y-boxes, as well as the PH domain) [12, 13] . This similarity is intriguing, although we do not yet know the function of p130, neither the native nor the expressed protein has any apparent catalytic activity towards inositol lipids. The reason for p130 not having PLC activity may result from a single amino acid deviation in each of two separate sequences of amino acids [12] that otherwise match well-conserved X-box subdomains that are a feature of all PLC enzymes [14] . However, this aspect of p130 also presented us with a complication. While these X-box motifs in PLC enzymes may determine catalytic activity, there is also the possibility of a noncatalytic PtdIns(4,5)P # binding function [15] . Perhaps in the case of p130 these particular domains have retained an ability to bind the polyphosphate moiety. This is difficult to predict from the primary sequence, because there is currently little information on inositol polyphosphate binding motifs. Thus our first goal was to determine the extent to which the PH domain of p130 is responsible for the protein's affinity for binding inositol polyphosphates. Fortunately, previous work with the purified protein [9] has established that p130 has only a single class of Ins(1,4,5)P $ binding sites.
There was another important reason for characterizing the regions of p130 that are responsible for binding inositol polyphosphates. This arises from the observation that the addition to Ins(1,4,5)P $ of either a 3-phosphate or a 6-phosphate sterically interferes with ligand binding to PLC-δ "
, reducing ligand affinity 10-fold or more [10, 11, 16] . The situation with regard to p130 is somewhat different ; although Ins(1,3,4,5)P % is not quite as good a ligand as Ins(1,4,5)P $ , the difference is only about 3-fold [9] . Moreover, Ins(1,4,5,6)P % was as efficacious as Ins(1,4,5)P $ itself at displacing [$H]Ins(1,4,5)P $ from full-length p130 [12, 16] . Again, the reason that the ligand binding characteristics of p130 are so exceptional may reflect the participation of regions that lie outside the PH domain. In particular, it would be a finding of particular relevance to efforts to determine the three-dimensional structure of PH domains if we could establish a precedent for at least one of these modules directly binding Ins(1,4,5,6)P % and Ins(1,4,5)P $ with equal affinity. The approach we have taken has been to express and analyse the polyphosphate binding characteristics of several deletion mutants of p130 in COS-1 cells, and ultimately of the PH domain itself. As a result of these studies, we not only determined that it is indeed the PH domain of p130 that binds Ins(1,4,5)P $ and Ins(1,4,5,6)P % , but we went on to derive some new information on other structural determinants of ligand specificity, by performing ligand displacement studies with a range of inositol derivatives. )P % using a purified multiple inositol polyphosphate phosphatase [23] .
MATERIALS AND METHODS

Materials
Construction of expression plasmids and truncation derivatives
A single XhoI site in the coding region of pcMT3 was destroyed by a silent mutation (at Arg#% ; CGA&$) to CGT&$)) directed with the synthetic oligonucleotide 5h-CGACCCTCGTGCCGGCG-CCGAT-3h. To generate a new XhoI site (C$*!,T$*" to T$*!,C$*") in the 5h-non-coding region of pcMT3, the synthetic oligonucleotide 5h-CCTTCTGGTGCTCGAGCGCACCCTTA-3h was used as a primer. The designed cDNA was digested with XhoI and inserted into the XhoI site of the mammalian expression vector XhoI\pSG5, which was modified by introducing EcoRVXhoI-NotI (GATATCTCGAGAGCGGCCGC) sites between the EcoRI and BglII sites of pSG5 (Stratagene). The orientation was confirmed by restriction endonuclease mapping and the resultant plasmid was designated construct I (full).
Truncated mutants were constructed by site-directed mutagenesis as follows. Two subclones were prepared for constructs II and III. One was an AflII-SmaI\construct I vector, in which an AflII site was introduced at position 400 of construct I, and was treated with bacterial alkaline phosphatase after being digested with AflII and SmaI. The other was pcMT3 (1-1356)\∆XhoI&$%, XhoI$)*, AflII%!!, which was subcloned into a pUC118 vector using an SmaI site after an AflII site was introduced at position 400. To form construct II, an NcoI site was introduced at position 810 and an NcoI site at position 1048 was destroyed on pcMT3 (1-1356)\∆XhoI&$%, XhoI$)*, AflII%!!. This cDNA clone was digested with NcoI and self-ligated. Then the self-ligated cDNA was digested with AflII and SmaI, and the desired DNA fragment was inserted into the pre-paired AflII-SmaI\construct I vector. The resultant plasmid was designated construct II (∆1-115). To make construct III, an NcoI site was introduced at position 1161 into pcMT3 (1-1356)\∆XhoI&$%, XhoI$)*, AflII%!!, and this clone was digested with NcoI to selfligate. The NcoI-self-ligated cDNA was digested with AflII and SmaI, and the desired DNA fragment was inserted into the prepaired AflII-SmaI\construct I vector. The resultant plasmid was designated construct III (∆1-232). For construct IV (∆727-1096) and construct V (∆851-1096), stop codons were introduced into construct I at positions 2645 and 3017 respectively. Construct VI was prepared as follows. A deletion mutant clone of pcMT3 (1-1356)∆XhoI&$%, XhoI$)*, AflIII%!! at nucleotides 470-748 was created by site-directed mutagenesis with the synthetic oligonucleotide 5h-TAGAACGTGCTTGGCCATG%'*G(%*TGTCTT-TCAGCAGCATGCCA-3h. The truncated clone was digested with AflII and SmaI, and the desired DNA fragment was inserted into the pre-paired AflII-SmaI construct I vector. The structure of the resultant plasmid was confirmed by restriction mapping analysis, and the molecular mass of protein product was checked by Western blotting using a monoclonal antibody against p130. Each plasmid (20 µg) was transfected into 5i10' COS-1 cells using liposomes (Lipofectamine reagent) according to the manufacturer's protocol. The transfected cells were cultured in Dulbecco's modified Eagle's medium containing 10 % (v\v) fetal calf serum in 10 cm dishes for 2 days.
Preparation of recombinant PH domain of p130
A cDNA fragment encoding the PH domain of p130 was generated by PCR on clone pcMT3 using the synthetic oligonucleotides 5h-ATGGATCCG(%*TGTCTTTCAGCAGCA-TGCC('*-3h and 5h-ATAAGCTTA""'#AAGTCAAGTGGTTG-CTTACTG""%"-3h as primers. The resultant DNA fragment was ligated into pT7 vector and the nucleotide sequence was confirmed. The clone was digested with BamHI and HindIII, and the desired DNA fragment was ligated to BamHI-HindIII-digested pQE30 His-tag vector (Quiagen). A construct expressing residues 95-232 of p130 was produced and purified as follows. After induction with isopropyl β--thiogalactoside (5 h), cells were lysed by sonication in 0.3 M NaCl and 50 mM phosphate buffer (pH 8.0). Triton X-100 was added to the homogenate to give a final concentration of 1 % (w\w), followed by incubation at 4 mC for 30 min. The mixture was centrifuged at 15000 g for 20 min and the resultant supernatant was mixed with a 50 % slurry of nitrilotriacetic acid resin at 4 mC for 1 h. Procedures for washing the resin and elution of adsorbed proteins were as described by the manufacturer. The isolated PH domain of p130 thus prepared was at least 95 % pure on an overloaded Coomassie Blue-stained SDS gel. The protein concentration was determined from an A #)! value at 1 mg\ml of 0.88 (ε l 14 000 M −" :cm −" .
Preparation of cytosol fraction from transfected cells, and assay of [ 3 H]Ins(1,4,5)P 3 binding
Transfected COS-1 cells from a dish were harvested in a buffer solution (250 µl) containing 50 mM NaCl, 10 mM Hepes buffer (pH 8.0), 1 mM EDTA, 1 mM NaN $ , 10 mM 2-mercaptoethanol and a cocktail of protease inhibitors (1.25 µg\ml pepstatin A, 10 µM leupeptin, 1 µg\ml aprotinin, 0.1 mM p-amidinophenylmethanesulphonyl fluoride) and lysed by passing cells through a 26G needle 15 times, followed by a centrifugation at 100 000 g for 60 min to obtain the cytosol fraction. The cytosol fraction was assayed for binding of [$H]Ins(1,4,5)P $ using a concentration of the latter of 1.3 nM, as described previously [9] .
PAGE, immunoblotting and quantification
The cytosolic fractions from each construct were separated in SDS\8 %-polyacrylamide gels and transferred to a PVDF sheet. The sheet was incubated for 1 h with monoclonal antibody (2F9) against p130 [16] after blocking with 5 % (w\v) dried milk solution, and then bound antibodies were visualized by the alkaline phosphatase reaction using biotinylated goat anti-(mouse IgG) and an avidin-biotin complex kit. The quantification of expressed protein on the developed sheet was done with an image analyser (IS-1000 ; Alpha Innotech Corp.). For quantification, one sample of cytosol of construct I, together with the samples to be examined, was subjected to electrophoresis and immunoblotting as a reference.
RESULTS
Localization of the Ins(1,4,5)P 3 /Ins (1, 4, 5, 6 )P 4 
binding site of p130
Our first goal was to locate the region in the p130 molecule that is responsible for binding of Ins(1,4,5)P $ , so we prepared several groups of COS-1 cells, each of which was transfected with cDNA encoding either full-length p130 (construct I) or one of its five different truncated versions (constructs II-VI). Figure 1(A) is a schematic representation of the various constructs. Figures 1(B) and 1(C) show Western blots of the constructs, which were obtained using two monoclonal antibodies against p130 (designated 4C1 and 2F9). In each case, the apparent molecular mass of the band recognized by the antibody coincided with the expected molecular sizes : 130 kDa (construct I), 105 kDa (construct II), 93 kDa (construct III), 80 kDa (construct IV), 93 kDa (construct V) and 108 kDa (construct VI). Note that the monoclonal antibody designated 4C1 failed to interact with constructs IV and V, indicating that it recognizes a region within residues 851-1096. Antibody 2F9, which interacted with all of the B C [12] ). In these experiments there was no significant difference in the total protein concentration of the cytosol fractions obtained from each plate of confluent cells. However, a densitometric survey of Westernblotted sheets (Table 1 , column 1) revealed some variation in the degree of expression of each construct. Therefore we normalized the binding activities of each construct to the amount of expressed protein (Table 1 , column 3). Construct I (the full-length protein) exhibited the largest capacity for [$H]Ins(1,4,5)P $ binding ( Table  1) . Deletion of portions of the C-terminus, as in construct IV (∆727-1096) and construct V (∆851-1096), reduced binding capacity by approx. 65 %. Removal of a portion of the Nterminus that included the PH domain (construct III ; ∆1-232) completely eliminated [$H]Ins(1,4,5)P $ binding activity. Note that binding to construct III was not observed even though it was expressed at a 14-fold higher concentration than construct I. Even when the concentration of [$H]Ins(1,4,5)P $ was increased 10-fold to 13 nM, no binding to construct III was evident (results not shown). Importantly, [$H]Ins(1,4,5)P $ did bind to construct II, which also has some of the N-terminus deleted (∆1-115), but in this particular case the region corresponding to the PH domain was intact. Our results (Table 1) indicate that residues 116-232 of p130 are essential for the binding of Ins(1,4,5)P $ . This region corresponds to the PH domain [12] . Nevertheless, some additional factors must have contributed to the differences between the ligand binding capacities of the constructs. We know that this variation was not due to the presence of multiple binding sites ; p130 has only one such site [9, 16] , and indeed the affinity of this site for Ins(1,4,5)P $ was similar in each construct where binding was detected [K d values for Ins(1,4,5)P $ : I, 3.4p0.3 nM ; II, 3.1p0.4 nM ; IV, 3.9p0.3 nM ; V, 2.9p0.4 nM]. It is possible that inappropriate folding of a variable proportion of each of the truncated constructs contributed to these differences in binding capacity.
Ins(1,4,5)P 3 binding to the isolated PH domain of p130
The data described above demonstrate that the PH domain of p130 is essential for the protein to bind inositol polyphosphates.
Figure 2 Binding of Ins(1,4,5)P 3 to the isolated PH domain of p130 (A) Scatchard analysis (B/F l bound/free) ; (B) displacement of [
3 H]Ins(1,4,5)P 3 bound to the PH domain by Ins(1,4,5)P 3 . Binding assays were performed essentially as described previously [9] . Results are meanspS.E.M. of four experiments.
The possibility was further explored by transfecting the cDNA for the PH domain itself (residues 95-232) into a bacterial expression system ; the domain was then extracted and purified (see the Materials and methods section). Figure 2 data directly demonstrate that the PH domain of p130 binds Ins(1,4,5)P $ . Nevertheless, the ligand affinity was about 3500-fold lower than that of the native protein (see Figures 3 and 4) , indicating that regions outside the PH domain contribute significantly to the overall ligand binding characteristics.
Ins(1,4,5)P 3 and Ins(1,4,5,6)P 4 bind to the same site on p130
The PH domain of PLC-δ " binds Ins(1,4,5,6)P % about 10-fold more weakly than Ins(1,4,5)P $ [10, 16] . When this result is considered in relation to X-ray crystallography data [11] , it appears that the the 6-phosphate of Ins(1,4,5,6)P % is a steric constraint on the ability of the molecule to be a ligand for the PH domain. In the case of p130, previous studies with the native protein [9, 16] 
Structural requirements of Ins(1,4,5)P 3 and Ins(1,4,5,6)P 4 for recognition by the PH domain of p130
The ligand specificity of p130 was studied by determining IC &! values for the displacement of [$H]Ins(1,4,5)P $ by a number of additional inositol phosphate derivatives (Table 2) . COS-1 cytosol containing construct V was particularly useful for these studies because it afforded the highest binding activity per unit of cytosolic protein (see Table 1 , column 2), while not exhibiting 
Table 2 Binding specificity of construct V, purified p130 and the isolated PH domain
Binding specificity was examined by the displacement of bound [ 3 H]Ins(1,4,5)P 3 at 1.3 nM. Each value represents the mean of three to four determinations. Inositol phosphates used were -isomers unless otherwise indicated. F209 is 2-O-(p-aminobenzoyl)-Ins(1,4,5)P 3 (for structure see [34, 35] ) ; F309 is 3-O-(p-aminobenzoyl)-Ins(1,4,5)P 3 (for structure see [36] [9] . † Values in parentheses for membranous p130 taken from [16] .
any significant differences in specificity compared with the native protein ( Table 2 ). The isolated PH domain also expressed a similar rank order of affinities for the various ligands but, as discussed above, the absolute ligand affinities were much reduced. We first examined the contributions made by the phosphate groups, beginning with the 5-phosphate. The importance of this group is revealed by two results. First, at concentrations of up to 3 µM, Ins(1,4)P # was unable to displace 1.3 nM [$H]Ins(1,4,5)P $ (Table 2) . Secondly, Ins(1,4,6)P $ was a 250-fold weaker ligand than Ins(1,4,5,6)P % . The 4-phosphate is also an important determinant of specificity, as Ins(1,5,6)P $ was nearly 500-fold more weakly bound than Ins(1,4,5,6)P % . Ins(4,5)P # was about 500-fold less effective a ligand than Ins(1,4,5)P $ , indicating that the 1-phosphate also makes an important contribution. The fact that the affinity for -Ins(2,4,5)P $ was intermediate between those of Ins(4,5)P # and Ins(1,4,5)P $ indicates that a phosphate at the 2-position can only partly substitute for the 1-phosphate ; the intermediate affinity of -Ins(2,4,5)P $ has also been observed with the native protein ( Table 2 in [9] ). GroPIns(4,5)P # was about 25-fold less potent than Ins(1,4,5)P $ , indicating either that a fully ionized 1-phosphate is important and\or that the glycerol moiety provides some steric hindrance. This result is unprecedented ; for all the other PH domains examined to date, a free monoester 1-phosphate is not critical, so they bind Ins(1,4,5)P $ with virtually the same affinity as GroPInsP # [2, 4, 5, 24, 25] . The fact that both Ins(1,4,5,6)P % and Ins(1,4,5)P $ bound with equal affinity could be because neither the 6-phosphate nor the 6-hydroxy group has much impact on specificity. Alternatively, it is possible that these two groups each interact with different amino acids, perhaps by hydrogen bonding, so that the absence of one interaction is quantitatively compensated for by the Figure 5 Structures of Ins (1, 4, 6 )P 3 and Ins (1, 3, 6 )P 3
The differences in the orientations of hydroxy groups of Ins(1,4,6)P 3 and Ins(1,3,6)P 3 compared with those of Ins(1,4,5)P 3 are shown by bold lines.
presence of the other. Further data indicate that this idea is feasible. For example, it appears that the 3-hydroxy group contributes to ligand specificity, presumably with a hydrogenbonding interaction, since its substitution with a 3-deoxy group reduced affinity 5-fold (Table 2 ). This proposed contribution of the 3-hydroxy group is also supported by the 5-fold reduction in affinity brought about when it was substituted by a bulky aminobenzoyl group (as in analogue F309 ; Table 2 ). However, when the 3-OH was replaced by another relatively bulky substituent, a phosphate group, there was only a 2.5-fold reduction in affinity (Table 2 ). This result suggests that the 3-phosphate has its own interactions with p130 that can partly compensate for the loss of the 3-OH. Arguably the strongest evidence that the 3-and\or 6-phosphates do interact with amino acids in p130 comes from our new observation that the affinity for Ins (3, 4, 5, 6 )P % was 20-fold higher than the affinity for Ins(4,5)P # ( Table 2 ). The contribution of the 2-hydroxy group was also studied. An analogue (F209) with a bulky aminobenzoyl substituent at the 2-position was similar in potency to Ins(1,4,5)P $ ( Table 2 ). We also found that 2-deoxy--Ins(1,4,5)P $ and -Ins(1,2,4,5)P % both had less than a 2-fold lower affinity than Ins(1,4,5)P $ ( Table 2 ). There was unlikely to be a contribution from the -enantiomers in these two racemic mixtures [since -Ins(1,4,5)P $ was not a significant ligand ; Table 2 ]. Therefore it seems that the 2-hydroxy group makes no contribution to ligand specificity. The latter conclusion is also supported by the observation that 3-deoxy-Ins(1,4,5)P $ had a similar affinity to 2,3-dideoxyIns(1,4,5)P $ ( Table 2 ). The poor affinity for both Ins(1,4,6)P $ and Ins(1,3,6)P $ (Table 2 ) was informative, in part because when these structures are inverted and rotated, they both satisfy the requirement for correctly oriented 1-, 4-and 5-phosphates of Ins(1,4,5)P $ ( Figure 5 ). However, in each case the orientation of the hydroxy groups fails to match that of Ins(1,4,5)P $ . Thus, although the hydroxy groups of Ins(1,4,5)P $ do not greatly contribute to specificity per se, if their orientation is switched between the axial and equatorial configurations then a steric constraint is probably introduced that substantially reduces ligand affinity.
DISCUSSION
A consensus is emerging that the binding of PtdIns(4,5)P # to some PH domains can target a parent protein to the plasma membrane ; more recently, some studies with PLC-δ " have raised the issue as to whether there might be PH domains where interactions with inositol phosphates could also be physiologically important [2, 26] . To investigate this issue, we have used a novel 130 kDa protein as a model system. This protein was originally isolated by Ins(1,4,5)P $ affinity chromatography [9, 16, 27] . We do not yet know the function of this protein and, although it shares approx. 38 % sequence identity with PLC-δ " , this similarity is insufficient to provide p130 with any lipid hydrolysing activity [9, 12] . Although p130 does have a PH domain, there are additional regions of this protein that could theoretically serve to bind inositol polyphosphates (see the Introduction section). Therefore it was significant that we were able to confirm that the PH domain does contain the Ins(1,4,5)P $ binding site. This conclusion arose from experiments using several truncated constructs of p130, which showed that loss of [$H]Ins(1,4,5)P $ binding was specific to deletion of the PH domain. Furthermore, the PH domain of p130 by itself (residues 95-232) was found to bind [$H]Ins(1,4,5)P $ ( Figure 2 ). Thus we have validated p130 as a useful paradigm for studying the interaction of inositol derivatives with the PH module.
Our further studies on the structural determinants of ligand specificity indicated that critical contributions were made by the 4-and 5-phosphates of the inositol ring (Table 2) . A similar conclusion has emerged from work with the PH domains of β-spectrin and PLC-δ " [4, 6] . However, in two other respects the PH domain of p130 exhibited some unusual features. First, a free 1-phosphate was necessary for a strong interaction of Ins(1,4,5)P $ with p130, since GroPIns(4,5)P # bound 25-fold more weakly ( Table 2 ). All the other PH domains that have been analysed to date have not shown a significant difference in affinity between Ins(1,4,5)P $ and GroPIns(4,5)P # [2, 4, 5, 24, 25] . Presumably the glycerol moiety provides a steric hindrance and\or blocks a negative charge of the 1-phosphate that is required for ligand binding to p130. Whatever the explanation, this observation strengthens the case for p130 providing the most credible example to date of an inositol phosphate being a physiologically important ligand for a PH domain. It will be interesting to discover how many other PH domains follow this particular prototype.
Our new data showing that the 3-and\or 6-phosphates can also provide sites of interaction with PH domains are also exceptional ; neither has been identified as being important previously [4, 6] , and the effect of their presence was even suggested from X-ray crystallographic analysis to impose steric hindrance [4, 6] . Indeed, our data indicate that Ins(1,4,5,6)P % should now be considered as potentially being a physiologically relevant ligand, not only for p130 but perhaps also for other PH domains. In relation to the search for a biological function for Ins(1,4,5,6)P % , this information provides the most intriguing clue uncovered so far.
Of course, determination of which of a series of ligands is actually physiologically relevant depends not just on relative binding affinities, but also on relative intracellular abundance. Cellular levels of Ins(1,4,5)P $ range from 1 µM (in ' resting ' cells), to 10 µM (in receptor-activated cells) (see [8] for a review). Levels of Ins(1,4,5,6)P % are also about 1 µM [28] . Since these two polyphosphates have apparent binding affinities in the low nanomolar region, they are both clearly capable of being physiologically relevant ligands. In the present study we have shown that p130 prefers a free monoester 1-phosphate ( Table 2 ), indicating that Ins(1,4,5)P $ and Ins(1,4,5,6)P % are much stronger ligands than PtdIns(4,5)P # However, we have not addressed the extent to which PtdIns(4,5)P # might compete in i o because of uncertainty over the free concentration of this lipid ; while total cellular levels have been estimated to be 30-160 µM [29] , local concentrations are likely to be higher. On the other hand, the availability of cellular PtdIns(4,5)P # for binding to p130 depends upon the affinities of the lipid for a range of other cellular proteins, including some that do not contain PH domains [30] [31] [32] .
The PH domain of p130 isolated from a bacterial expression system could bind [$H]Ins(1,4,5)P $ , and showed a similar specificity to that of the native protein ( Table 2 ). These data indicate that the PH domain itself forms a minimal structural module for accommodating Ins(1,4,5)P $ . However, the affinity for inositol polyphosphate binding was about 3500-fold lower than that seen with the parent protein. Therefore the tertiary structure of the isolated PH domain may not necessarily be the same as that in the whole molecule. For example, the orientations and\or bond lengths of hydrogen bonds and salt-bridges for the interaction between Ins(1,4,5)P $ and the PH domain may be different from those formed with the whole protein. Alternatively, the isolated PH domain may not contain all the sites that are normally available for ligand interactions. This issue is relevant to the increasing use of isolated PH domains to study the properties of ligand binding [4, 5] . Although the PH domain of PLC-δ " binds Ins(1,4,5)P $ with similar affinity to that of the fulllength protein [33] , our data indicate that it may not generally be valid to extrapolate information obtained with the isolated PH domain to the native protein. The characterization of the relationship between primary sequence, tertiary structure and ligand binding characteristics, at least in the case of p130, will require a more complex analysis of the contributions of regions of the protein that lie outside the PH domain. Further studies with NMR spectrophotometric and X-ray crystallographic analyses are currently in progress in this laboratory to pursue this very issue.
